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Abstract
Background: Excessive accumulation of lipids in the adipose tissue is a major problem in the
present-day broiler industry. However, few studies have analyzed the expression of adipose tissue
genes that are involved in pathways and mechanisms leading to adiposity in chickens. Gene
expression profiling of chicken adipose tissue could provide key information about the ontogenesis
of fatness and clarify the molecular mechanisms underlying obesity. In this study, Chicken Genome
Arrays were used to construct an adipose tissue gene expression profile of 7-week-old broilers,
and to screen adipose tissue genes that are differentially expressed in lean and fat lines divergently
selected over eight generations for high and low abdominal fat weight.
Results: The gene expression profiles detected 13,234–16,858 probe sets in chicken adipose
tissue at 7 weeks, and genes involved in lipid metabolism and immunity such as fatty acid binding
protein (FABP), thyroid hormone-responsive protein (Spot14), lipoprotein lipase(LPL), insulin-like growth
factor binding protein 7(IGFBP7) and major histocompatibility complex (MHC), were highly expressed.
In contrast, some genes related to lipogenesis, such as leptin receptor, sterol regulatory element binding
proteins1 (SREBP1), apolipoprotein B(ApoB) and insulin-like growth factor 2(IGF2), were not detected.
Moreover, 230 genes that were differentially expressed between the two lines were screened out;
these were mainly involved in lipid metabolism, signal transduction, energy metabolism,
tumorigenesis and immunity. Subsequently, real-time RT-PCR was performed to validate fifteen
differentially expressed genes screened out by the microarray approach and high consistency was
observed between the two methods.
Conclusion: Our results establish the groundwork for further studies of the basic genetic control
of growth and development of chicken adipose tissue, and will be beneficial in clarifying the
molecular mechanism of obesity in chickens.
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Background
The chicken is an important model organism that bridges
the evolutionary gap between mammals and other verte-
brates [1]. Research on chickens (Gallus gallus) has had a
significant impact on fundamental biology. The domestic
chicken also provides a major protein source from meat
and eggs for most human populations throughout the
world. Its economic importance has made it the focus of
numerous research projects, including a recent effort to
sequence the entire chicken genome [2].
During the past 80 years, selective breeding has made
spectacular progress in both egg and meat production
traits. The modern commercial broiler is the product of
intensive selection for rapid growth and enhanced muscle
mass over many generations. Associated with these suc-
cesses there have been a number of undesirable traits,
such as ascites and lameness, reduced fertility, and
reduced resistance to infectious diseases [3]. Selection for
rapid growth has been also accompanied by increased fat
deposition in these animals [4,5]. Excessive fat is a major
problem for the modern broiler industry, since it not only
reduces carcass yield and feed efficiency, but also causes
rejection of the meat by consumers [6] and difficulties in
processing [7].
With the rapid development of molecular biotechnology,
various studies have been performed to investigate the
metabolic and genetic mechanisms involved in the regu-
lation of fatness in chickens. Because de novo fatty acid
synthesis in birds takes place mainly in the liver, most
studies have been performed on hepatic tissue. There have
been few analyses of the expression of adipose tissue
genes involved in pathways and mechanisms leading to
adiposity in chickens. In the present study, Chicken
Genome Arrays were used to construct the gene expres-
sion profiles of 7-week-old broilers, and to screen genes
that are differentially expressed in adipose tissue between
lean and fat lines divergently selected over eight genera-
tions for high and low abdominal fat weight. Our study
will be beneficial in clarifying the molecular mechanisms
of obesity in chicken, and these data will contribute to
related research on other species.
Results
Characterization of the two chicken lines
It is clear that the percentages of abdominal fat in the two
lines have become very different after selecting for eight
generations (Figure 1). In the eighth generation, the AFP
is 2.95% in the fat chicken line and 1.55% in the lean line.
The chickens used in this study differed significantly not
in body weight but in abdominal fat weight and percent-
age of abdominal fat (Figure 2) and were chosen on that
basis. AFP in the fat line was three times that in lean line
(Table 1).
Adipose tissue gene expression profile
The pattern of adipose tissue gene expression of chickens
at 7 weeks was analyzed by oligonucleotide microarrays.
Normalized data were used to analyze the total expressed
genes. Depending on the individual bird, 13,234–16,858
probe sets were detected (bird 7-3-16 was excluded from
subsequent analysis for the reason given below). Subse-
quently, the distribution of expression levels of genes in
adipose tissue was calculated by JMP4.0 (Figure 3). The
genes were ordered according to their mean expression
levels; those with expression levels in the highest or lowest
1% were considered highly expressed or the converse.
Some of the genes with especially high or low expression
levels are named in Tables 2 and 3.
The separation of AFP between fat and lean lines Figure 1
The separation of AFP between fat and lean lines. 
The lean and fat chicken lines derived from a commercial 
Arbor Acres (AA) grandsire line were created at the North-
east Agricultural University Animal Breeding Center in 1996. 
They have been selected for 8 generations up to 2004. The 
selection criteria were the proportion of abdominal fat and 
levels of very low density lipoproptein (VLDL) in males at 7 
weeks of age. Significant differences in AFW and AFP 
between the two lines were apparent from the 4th genera-
tion. Selection was continued for 8 generations, with 15 sires 
and 4 hens per sire in each line for the G0 to G5 generations 
and 25 sires and 4 dams per sire in each line for generations 
G6 to G8. The number of fat line chickens from G1 to G8 
was: 82, 88, 75, 81, 80, 78, 179, 165, respectively; and in lean 
line from G1 to G8: 124, 133, 127, 141, 139, 145, 258, 219, 
respectively. G represents generation. **p < 0.01, significant 
difference in AFP between the two lines.BMC Genomics 2007, 8:193 http://www.biomedcentral.com/1471-2164/8/193
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We also believe that genes described as "not expressed"
can provide useful information about the function of adi-
pose tissue and lipid metabolism in chicken. Table 4
shows some of these genes, selected using the software
Affymetrix Microarray Suite 4.0. Many genes allegedly
involved in lipid metabolism and obesity were not
expressed in adipose tissue in the 7-week-old chickens.
Analysis of consistency within the fat and lean lines
Although there is little difference among individuals in
the AFW and AFP within each line, individuals in each
line may differ in hereditary molecular characters. By
comparing the consistency within each line, the selective
effect can be evaluated properly, and chickens that deviate
too much from the norm can be excluded from subse-
quent screening of differentially expressed genes. This
makes the analysis of differentially expressed genes more
reliable and credible. The cluster analysis results showed
that the fat line individuals, except chicken 7-3-16, were
more consistent that the lean line ones. Chicken 7-3-16
deviated too much from the other fat line chickens
(R<0.6) so it was excluded from the screening of differen-
tially expressed genes. The hierarchical clustering results
are shown in Figure 4.
Identification of differentially expressed genes
In order to identify the differentially expressed genes, Sig-
nificance Analysis of Microarrays (SAM) was performed
on normalized data as described by Tusher et al. [8]. To
avoid the low-variance problem in t-tests, SAM uses a sta-
tistical method similar to the t-test and estimates the false
discovery rate by permutation of repeated measurements
[8]. Subsequently, a two-class SAM analysis was per-
formed on the log transformed data matrix (see Materials
and Methods). A cutoff value, delta, depending on an
arbitrary false positive rate, was chosen to identify genes
that were significantly differentially expressed. For this
analysis, a delta value of 0.8 was used (Figure 5). This led
to the identification of a total of 230 differentially
expressed genes: 153 were up-regulated and 77 were
down-regulated in fat chickens compared to lean chickens
(Figure 6). Highly differentially expressed genes were fur-
ther selected by the fold change (fat/lean). These differen-
tially expressed genes were mainly involved in lipid
metabolism, energy metabolism, signal transduction,
immunity and tumorigenesis. Table 5 is a summary of the
most representative of these genes.
Validation of gene expression data by quantitative real-
time PCR
To validate the microarray results, we performed quantita-
tive real-time PCR for: propionyl-coenzyme A-carboxylase
(PCC), similar to 1-phosphatidylinositol-4,5-bisphosphate
phosphodiesterase gamma 2 (PBP2), tumor necrosis factor,
alpha-induced protein 1 (TNFAIP1), fms-related tyrosine
kinase 1 (FLT1), glycerol-3-phosphate dehydrogenase 2
(G3PD), low density lipoprotein-related protein 12 (LRP12),
prostaglandin E receptor 3 (PER), suppression of tumorigenic-
ity 7 (ST7), similar to endoplasmic reticulum oxidoreductin 1-
Lbeta (ERO1), ataxin 3 (ATXN3), parvin, alpha (PARVA),
CWF19-like 2 (CWF19), similar to Stxbp4 protein (Stxbp4),
acyl-CoA oxidase (ACO), and suppressor of cytokine signaling
7(SOCS7) (Table 6). In all but one case (TNFAIP1), the
real-time RT-PCR fold differences were in complete corre-
spondence with the microarray data. Table 7 compares the
microarray and real-time RT-PCR results.
Table 1: BW, AFW and AFP of chickens used in the study
Fat line Lean line
7-3-3 7-3-8 7-3-15 7-3-16 7-3-24 7-1-1 7-1-2 7-1-4 7-1-11 7-1-17
BW(g) 2690 2615 2915 2940 2895 2655 2655 2080 2375 2685
AFW(g) 103.4 116.6 115.3 112.1 138.4 36.91 40.13 28.27 23.46 40.83
AFP (%) 3.84 4.46 3.96 3.81 4.78 1.39 1.51 1.36 0.99 1.52
Comparison of BW, AFW and AFP in chickens used in the  study Figure 2
Comparison of BW, AFW and AFP in chickens used 
in the study. The birds were kept in similar environmental 
conditions and had access to feed and water ad libitum, and 
were fed with a commercial corn-soybean-based diet that 
met all NRC requirements for 7 weeks. BW was measured 
after 12 hours fasting, then the birds were slaughtered and 
the abdominal fat was isolated and weighed. The AFP was 
calculated as AFP (%) = AFW (g)/BW (g). BW, AFW and AFP 
data for the ten birds are shown in Table 1. BW is not signif-
icantly different between the two lines, but AFW and AFP 
differ significantly. Data are mean ± SD (n = 5). **p < 0.01, 
significant difference between fat line and lean line.BMC Genomics 2007, 8:193 http://www.biomedcentral.com/1471-2164/8/193
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Discussion
Because de novo fatty acid synthesis in birds takes place
mainly in the liver, most studies have been performed on
hepatic tissues. The expression of some genes involved in
lipid synthesis and secretion has been analyzed in the liver
of lean and fat chickens. Bourneuf et al. [9] used a cDNA
microarray to analyze the expression of genes in liver that
are involved in pathways and mechanisms leading to adi-
posity, and found some genes differentially expressed
between lean and fat chickens. Their research indicated
that the mechanisms involved in the expression and regu-
lation of lipogenic genes could play a key role in the
ontogenesis of fatness in chickens from lean and fat lines.
However, few studies have analyzed the functions of adi-
pose tissue leading to adiposity in chickens.
Genome expression analysis aims to provide a broad and
unbiased survey of the transcriptome, and requires true
global coverage of a complex genome in a single microar-
ray [10]. Significant progress has been made towards this
goal and GeneChip microarrays have been improved sig-
nificantly since they were invented [11].
The Chicken Genome Array, created by Affymetrix Inc. at
the end of 2004 as part of the Ensembl annotation
attempt at the complete chicken genome sequence (ver-
sion 1, released May 2004), is a key research tool in
chicken genomics. Our study provides, apparently for the
first time, a comprehensive analysis of the chicken adi-
pose tissue gene expression profile using this array. The
gene expression profile results showed that 13,234–
16,858 probe sets were detected in adipose tissue in 7-
Table 2: Some highly expressed genes in chicken adipose tissue at 7 weeks
The signal intensity analyzed by scanner
Genes Fat line Lean line
7-3-3 7-3-8 7-3-15 7-3-16 7-3-24 7-1-1 7-1-2 7-1-4 7-1-11 7-1-17
A-FABP 44732 47715 46157 57201 52558 52286 49813 51861 50529 47910
spot 14 33917 30120 28795 35261 36359 19983 25819 24245 31674 31015
LPL 27133 24469 29421 25855 30799 18393 20950 23462 25275 23246
IGFBP-7 20471 22532 21163 27799 24675 24113 25764 29104 26375 28610
BMP7 29042 30313 25289 25124 22610 15932 24165 13953 26518 33345
hsp70 33480 32478 30641 21373 23217 19213 21624 16512 21503 30312
PCHK23 21402 19941 19423 30817 30956 29866 25764 24882 22561 25995
hsp25 32908 19470 23662 21037 25644 19327 7967 22002 19564 27742
glutathione peroxidase 4 22459 21447 24945 23085 24229 18705 23685 27400 27560 24096
stem cell antigen 2 32224 31256 22169 24894 26446 21403 27675 24483 26370 26105
CD74 gene 45284 38191 36116 38875 37099 43381 38466 32027 40065 39493
Vimentin 38624 36822 37965 33403 35772 36159 40251 41728 40184 40972
ubiquitin C 42501 37306 45125 39121 35707 35202 40535 42767 43055 41982
Thymosin beta 4 35340 33804 38768 34644 30105 42836 37625 34939 36087 37120
MCH II antigen B-L Beta 32147 29581 28406 34359 28741 38580 30089 29337 28674 31680
T-cell leukemia, homeobox 3 26240 29169 34325 24093 24060 36533 29476 28294 28493 31986
platelet/endothelial cell adhesion molecule 21515 16459 10731 12262 13868 16684 18476 17751 14270 17975
The distribution of genes expressed in adipose tissue calcu- lated by JMP Figure 3
The distribution of genes expressed in adipose tissue 
calculated by JMP. Raw data sets were normalized to total 
fluorescence, which represents the total amount of cRNA 
hybridized to a microarray using the software Affymetrix 
Microarray Suite 4.0. Data sets were excluded if the absolute 
call (Abs Call) was A (absent) or M (Marginal) according to 
the detection p-value in all arrays. Only expressed transcripts 
(the Abs Call was P, present) were used in the analysis. The 
y-axis is the signal intensity after normalization, which repre-
sents the relative expression level of genes. The signal inten-
sity of most genes was under 10,000, that most genes are 
poorly expressed in chicken adipose tissue at 7 weeks.BMC Genomics 2007, 8:193 http://www.biomedcentral.com/1471-2164/8/193
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week-old chickens. Further study revealed that genes
directly involved in lipid metabolism, including Spot14,
LPL, adrenomedullin, pyruvate dehydrogenase kinase, isoen-
zyme 4 and the FABP family: FABP 3 (muscle and heart),
FABP 4 (adipocyte) and FABP 5 (psoriasis-associated), were
highly expressed in adipose tissue; FABP 4 is the most
highly expressed gene in this tissue. These genes are
mainly involved in fatty acid transport and degradation.
Other genes that are closely related to lipid metabolism
and obesity by signal transduction or regulation of tran-
scription were also highly expressed: prosaposin (PSAP),
retinol binding protein 7 (RBP7), retinoic acid receptor
responder, IGFBP 7, thymosin beta 4, BMP7, superoxide dis-
mutase 2 and  annexin A5. In addition, many genes
involved in the immune response and cytophylaxis, such
as CD74 antigen, MHC class I glycoprotein, MHC class II beta
1 domain, MHC class II antigen alpha, lymphocyte antigen 6,
beta-2 microglobulin, T-cell leukemia, Hsp70 and  Hsp25,
were also highly expressed in adipose tissue. The most
highly expressed genes (A-FABP, LPL) were apparently not
differentially expressed between fat and lean lines. This
may not preclude a major involvement of these factors in
regulating lipid metabolism in chick adipose tissue, and
further work on protein expression is needed to under-
stand the metabolism of this tissue better. Our results
demonstrated primarily that the functions of adipose tis-
sue in chicken are important in lipid metabolism by
directly or indirectly regulating the synthesis, transport
and degradation of lipids. Moreover, adipose tissue may
play an important role in chicken immunity and cytoph-
ylaxis. These results will be help to clarify the adipose tis-
sue gene expression profile and to choose appropriate
methods for further study of these genes.
On the other hand, genes described as "not expressed",
including obr,SREBP1, apoB,CCK,CCKR,IGF2 and lipopro-
tein (APOVLDLII), which have been studied extensively in
other species (mainly Homo sapiens and Mus) and shown
to affect obesity, were not detected in chicken adipose tis-
sue in the present study. Possible reasons may be: (1)
these genes are not expressed in chicken adipose tissue at
all, or not at 7 weeks; (2) lipid metabolism in chicken is
different from that in mammals. In birds, lipogenesis
mainly occurs in the liver and is very limited in adipose
tissue [12]. Although those genes were not detected in adi-
pose tissue, they may regulate lipid metabolism indirectly.
Another possible reason is gene interactions: the highly
expressed genes may inhibit those with low expression
levels and the "not expressed" ones when they participate
the same biological responses.
Genetic variation in fatness was analyzed using two exper-
imental lines (fat (FL) and lean (LL)) that were divergently
selected for abdominal fat weight from a common genetic
background. After selection for eight generations, the AFW
and AFP differed significantly between the two lines (Fig-
ure 2). By consistency analysis within each line using hier-
archical clustering of the total expressed genes,
heterogeneity among individuals in each line was demon-
strated (Figure 4). The hierarchical clustering results were
barely satisfactory: the fat line showed higher consistency
(about 87%) than the lean (about 77%). The consistency
Table 3: Some poorly expressed genes in chicken adipose tissue at 7 weeks
The signal intensity analyzed by scanner
Genes Fat line Lean line
7-3-3 7-3-8 7-3-15 7-3-16 7-3-24 7-1-1 7-1-2 7-1-4 7-1-11 7-1-17
IGF-I 5.7 11.3 91 7 5.8 52 27.6 22.7 46.6 91.6
UCP 43.3 87.1 104.2 130 119.4 122.2 818.2 289.2 159.6 150.6
APOVLDLII 140.1 103 75.8 107.3 156.2 298.3 72.5 22.6 143.8 98.4
L-FABP 57.7 70.6 126.9 32.6 128.3 623.8 844.5 88.8 52.4 4865
TGFa 115.1 216.8 79.8 51 94.3 186.6 37.7 49.7 166.1 95.8
TGFβR 82.3 151.7 83.3 153.6 146 279.6 166.3 221.9 140.6 191.4
PEPCK-M 503.8 206.3 326 38.1 117.3 404.2 154.2 150.5 140 198.6
BMP2 236 355.4 262.7 317.2 430.9 209.3 399.6 228.6 337 208.6
acetyl-coenzyme A carboxylase alpha 232.5 181.8 319.5 396.4 172.9 181.7 160.8 207.1 144.9 111.8
type I TGF β receptor 82.3 146 153.6 83.3 151.7 191.4 140.6 221.9 279.6 166.3
cAMP response element- binding protein 96.9 115.5 132.3 75 146.5 171.6 91 82.7 196.4 132.6
hexokinase 2 (HK2) 270.3 458.9 526.4 779.8 287.3 523 471.5 337.2 294.7 398.3
Proinsulin 263 269.5 361 540.1 293 336 311 411.1 422.6 190.2
GDF-9 198.1 197.8 216.7 413 190.7 246.8 151.7 110.6 262.9 147.2
BMP5 216.3 382.1 179.5 241.8 257.8 132.2 282.2 264.5 173 288.6
mitogen-activated protein kinase phosphatase 2 231.5 288.2 247.1 238.6 280.5 239.6 136.8 415.3 300.7 205.1
(MKP-2) riboflavin-binding protein 239.7 17.6 179 75.8 242.5 139.8 424.4 60.8 129.9 291.4BMC Genomics 2007, 8:193 http://www.biomedcentral.com/1471-2164/8/193
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of each line is not sufficiently maintained. There may be
two reasons for this. First, an insufficient number of gen-
erations have been used for selection, so the purity of each
line will increase as selection continues. Second, our tar-
get trait is abdominal fat; after selection for eight genera-
tions the genes affecting abdominal fat may be better
selected, but the genome array detects all genes expressed
in adipose tissue, so genes affecting other traits, which
have not been divergently selected, will reveal inter-indi-
vidual differences within each chicken line. The higher
consistency of the fat chicken line (about 87% compared
to 77% for the lean line) shows that the fat line is purer
than the lean line after being selected for eight genera-
tions. In addition, to make our study more reliable, the 7-
3-16 individual was excluded from subsequent screening
of differentially expressed genes because it deviated too
much from the others.
Significance Analysis of Microarrays (SAM) has been con-
sidered a canonical algorithm for identifying differentially
expressed genes in microarray data analysis. A total of 230
differentially expressed genes were screened by SAM. Fif-
teen genes that were differentially expressed between the
two chicken lines were validated by real-time RT-PCR. To
validate the results further, in addition to the samples
used in the array experiments, four RNA pools (two from
the fat line and two from the lean) were used for real-time
RT-PCR analysis to reveal the differentially expressed
Table 4: Some "not expressed" genes in adipose tissue of 7-week-old chickens
Probe set ID Genes mismatching probes pairs/the total probes pairsa
Gga.10702.1.A1_at insulin-like growth factor 2 10/10
Gga.11305.1.S1_s_at thyroid hormone receptor associated protein 2 10/10
Gga.11817.1.S1_s_at apolipoprotein B 10/10
Gga.12348.2.S1_a_at glycosyltransferase 10/10
Gga.13.1.S1_s_at leptin receptor 10/10
Gga.4123.1.S1_at lipoprotein (APOVLDLII) 10/10
Gga.1731.1.S1_at pyruvate carboxylase 10/10
Gga.742.1.S1_at somatostatin-14 10/10
Gga.1267.1.S1_a_at growth hormone 1 10/10
Gga.560.1.S1_at growth differentiation factor 8 10/10
Gga.5646.2.S1_at diacylglycerol kinase, zeta 104 kDa 10/10
GgaAffx.21833.1.S1_s_at cholecystokinin receptor 10/10
GgaAffx.21834.1.S1_s_at cholecystokinin 10/10
GgaAffx.21846.1.S1_s_at transforming growth factor alpha 10/10
GgaAffx.2229.1.S1_at polyamine oxidase (exo-N4-amino) 10/10
Gga.579.1.S1_at neurotrophic tyrosine kinase, receptor, type 1 10/10
Gga.609.1.S1_at thyroid hormone receptor beta 2 10/10
Gga.151.1.S1_at sterol regulatory element binding transcription factor 1 10/10
Gga.686.1.S1_at bone morphogenetic protein 4 10/10
Gga.689.1.S1_at low density lipoprotein-related protein 1 10/10
Gga.15741.1.S1_at growth arrest-specific 2 10/10
Gga.16782.1.S1_at phosphoinositide-3-kinase, catalytic 10/10
Gga.761.1.S1_at Mel-1c melatonin receptor 10/10
Gga.762.1.S1_at melatonin receptor 1 10/10
Gga.784.1.S1_at protein-tyrosine phosphatase CRYPalpha 10/10
Gga.793.1.S1_s_at acetylcholinesterase 10/10
Gga.811.1.S1_at growth differentiation factor 2 10/10
Gga.17381.1.S1_at phospholipase C-like 3 10/10
Gga.857.1.S1_at epidermal growth factor receptor 10/10
Gga.6214.1.S1_a_at phospholipase A2, group IB (pancreas) 10/10
Gga.3663.2.S1_at nucleolin 10/10
Gga.3707.2.A1_at CCAAT/enhancer binding protein (C/EBP), gamma 10/10
GgaAffx.2229.1.S1_at polyamine oxidase (exo-N4-amino) 10/10
GgaAffx.3695.1.S1_s_at myelin transcription factor 1 10/10
GgaAffx.3803.6.S1_at plexin A1 10/10
Gga.2645.1.S1_at transforming growth factor, beta receptor II 10/10
Gga.2694.1.S1_at lymphoid enhancer-binding factor 1 10/10
Gga.271.1.A1_at bone morphogenetic protein 1 10/10
Gga.2933.1.S1_at N-acetylglucosaminyltransferase VI 10/10
GgaAffx.20398.1.S1_s_at phospholipase C-like 3 10/10
a: mismatching probes pairs in the total probes (10 pairs) that represent certain genes.BMC Genomics 2007, 8:193 http://www.biomedcentral.com/1471-2164/8/193
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genes more exactly. The results of this validation were
encouraging: in all but one case (TNFAIP1), the real-time
RT-PCR fold differences correlated well with the microar-
ray data. Rajeevan et al. [13] evaluated the efficiency of
real-time RT-PCR for validating the differentially
expressed genes identified by microarrays. Their results
indicated that genes showing less than a 2-fold difference
in expression were not likely to be validated by real-time
RT-PCR. Bourneuf et al. [9] considered that confirmation
of genes with fold changes <1.7 by microarray analysis
and/or <2 by real-time RT-PCR was difficult and likely to
produce false positives. According to this report, the fold
change of TNFAIP1 in the microarray was -1.6, which is
difficult to confirm by real-time RT-PCR, so it is not cor-
rect to affirm that the two methods gave contradictory
results for this gene.
Our analysis results revealed that the expression levels of
some important genes implicated in lipid metabolism
were up-regulated in fat chickens: propionyl-coenzyme A-
carboxylase, acyl-CoA oxidase, pyruvate dehydrogenase com-
plex, glycerol-3-phosphate dehydrogenase, phosphatidylinositol,
lysophospholipase 3, low density lipoprotein-related protein 12,
etc. Pyruvate dehydrogenase catalyzes oxidative decarbox-
ylation of pyruvate to form acetyl-CoA, which is a central
metabolite [14-16]. Acetyl-CoA enters the Krebs cycle, and
is the donor of acetate for synthesis of fatty acids, ketone
bodies and cholesterol. The expression level of glycerol-3-
phosphate dehydrogenase increased in diet-induced obese
animals [17]. Propionyl-coenzyme A-carboxylase is the key
enzyme in the catabolism of odd-chain fatty acids, isoleu-
cine, threonine, methionine and valine [18]. Phosphati-
dylinositol is an important lipid, both as a key membrane
constituent and as a participant in essential signaling
processes in all plants and animals. These genes regulate
lipid metabolism mainly by enhancing the synthesis of
fatty acids. In addition, the expression of genes involved
in energy metabolism, such as thioredoxin-like 4B, 5-oxo-
prolyl-peptidase, etc., were markedly down-regulated in fat
line chickens, and the expression of genes participating in
gluconeogenesis or glycolysis, including glycerol kinase
(GK), ATPase, beta 1,3-galactosyltransferase etc. were up-
regulated in this line. In fact, it is well recognized that
both energy metabolism [19] and glycometabolism
[20,21] are highly related to obesity.
It is interesting that several genes in the protein tyrosine
phosphatase pathway were more highly expressed in fat
than in lean chickens: fms-related tyrosine kinase 1, receptor
tyrosine kinase flk-1/VEGFR-2, a type III receptor tyrosine
kinase, protein tyrosine phosphatase-like, member b, protein-
tyrosine phosphatase MEG2, etc. This indicates that the pro-
tein tyrosine phosphatase pathway is very important in
lipid metabolism, and further research is needed to eluci-
date the molecular mechanism.
SAM Plot for Delta = 0.8 Figure 5
SAM Plot for Delta = 0.8. Differentially expressed genes 
were identified from normalized data using the Significance 
Analysis of Microarrays (SAM) algorithm implemented in a 
TIGR MultiExperiment Viewer. A cutoff value delta, depend-
ing on an arbitrary false positive rate, was chosen to identify 
significantly differentially expressed genes. For this analysis, a 
delta value of 0.8 was used, giving a reasonable cutoff of 3.13 
and 4.73 in d-scores.
The hierarchical clustering results of five fat line and five lean  line chickens Figure 4
The hierarchical clustering results of five fat line and 
five lean line chickens. A: hierarchical clustering results 
for five fat line chickens. B: hierarchical clustering result for 
five lean line chickens. The data used for clustering were nor-
malized data that excluded the "not expressed" genes. R rep-
resents the coefficient of correlation among individuals. The 
fat chicken line shared about 87% consistency, while the lean 
chicken line shared about 77% consistency. Sample 7-3-16 
shared only 59% consistency with the other fat line chickens, 
so it was excluded from the subsequent screening of differ-
entially expressed genes.
A 
B BMC Genomics 2007, 8:193 http://www.biomedcentral.com/1471-2164/8/193
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Adipogenesis is promoted by the coordinated expression
of many transcription factors [22,23]. De-differentiation,
or loss of the adipocyte phenotype, has been observed in
response to tumor necrosis factor and transforming
growth factor β [24,25]. We also observed that several
genes involved in tumorigenesis were differentially
expressed between the two chicken lines. Expression of
genes that inhibit tumorigenesis, such as tumor necrosis
factor, alpha-induced protein 1, suppression of tumorigenicity
7 and thrombospondin 1, was down-regulated in fat line
chickens, while the expression of genes promoting tumor
formation, including ret proto-oncogene and turban tumor
syndrome, was up-regulated. This indicates that tumorigen-
esis may be related to obesity. TNFAIP1 was first identified
as a tumor necrosis factor a (TNFa) and interleukin-6(IL-6)
inducible protein. It is induced rapidly and transiently by
TNFa [26]. It is inferred that the in vivo effects of LPS on
lipid metabolism are probably mediated by TNFa, which
could be secreted by macrophages or by the adipose tissue
itself [27,28]. Albalat et al. [29] suggested that TNFa could
be a key modulator of lipid metabolism in fish. Taking
these reports and our data into consideration, we presume
that TNFa  may play a significant role in chicken lipid
metabolism.
Conclusion
In conclusion, the chicken adipose tissue gene expression
profile was investigated comprehensively in the present
study, and specific genes that were differentially expressed
in adipose tissue between a fat and a lean chicken line
were identified with the aid of the Chicken Genome Array.
Genes with high and low expression levels and "not-
expressed" genes were identified, and 230 genes that were
differentially expressed between the two chicken lines
were screened out and confirmed by real-time RT-PCR.
These genes were mainly involved in lipid metabolism,
energy metabolism, signal transduction, tumorigenesis
and immunity. Further analysis indicated that the pyru-
vate dehydrogenase complex, propionyl-coenzyme A-car-
boxylase, TNFa and the protein tyrosine phosphatase
pathway may play key roles in lipid metabolism. If con-
firmed in future studies, these patterns of gene expression
may contribute to understanding the molecular mecha-
nism of obesity in chickens and provide potential targets
for future therapy in humans.
Methods
Lean and fat chicken lines
The NEAU broiler lines divergently selected for abdomi-
nal fat content (NEAUHLF) have been selected since 1996
using percentage abdominal fat (%AFW) and plasma very
low-density lipoprotein (VLDL) concentration as selec-
tion criteria. The G0 generation of the two lines came from
the same grandsire line originating from the Arbor Acres
breed, which was then divided into two lines according
plasma VLDL concentration at 7 weeks. From G1 to G8,
birds of each line were raised in two hatches. They were
kept in similar environmental conditions and had access
to feed and water ad libitum, and were fed with a commer-
cial corn-soybean-based diet that met all NRC require-
ments (National Research Council, 1994). From hatching
to 3 weeks the birds received a starter feed (3,100 kcal ME/
kg and 210 g/kg CP), and from 4 weeks to slaughter they
were fed a grower diet (3,000 kcal ME/kg and 190 g/kg
CP). Plasma VLDL concentrations were measured for all
birds at 7 weeks. Abdominal fat weight (AFW) of the male
birds in the first hatch was measured and adjusted
(%AFW) for body weight (BW) after slaughtering at 7
weeks. Birds with plasma VLDL concentration and AFP
lower (lean line) or higher (fat line) than the population
average value were selected as candidates for breeding,
considering the body weights of male birds and egg pro-
duction of female birds.
Selection was continued for 8 generations, with 15 sires
and 4 hens per sire in the fat line and 10 sires and 4 hens
per sire in the lean line for the G0 to G5 generation, then
25 sires and 4 dams per sire in each line for generations
G6 through G8. The phenotypic correlation coefficient
between body weight and AFW is 0.3789 (P < 0.01), and
Cluster image of 230 significant differentially expressed genes Figure 6
Cluster image of 230 significant differentially 
expressed genes. A total of 230 differentially expressed 
genes were identified by SAM algorithm: 153 were up-regu-
lated and 77 were down-regulated in fat chickens compared 
to lean chickens. Colored bars indicate relative expression 
levels. Genes that are expressed at higher levels are assigned 
progressively brighter shades of red, while genes expressed 
at low levels are assigned shades of green.B
M
C
 
G
e
n
o
m
i
c
s
 
2
0
0
7
,
 
8
:
1
9
3
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
1
6
4
/
8
/
1
9
3
P
a
g
e
 
9
 
o
f
 
1
4
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
)
Table 5: Differentially expressed genes by microarray analysis
Probe set ID Fold Change (fat/lean) T-test P-value SAM q-value Chr. Location GenBank ID Gene name
Lipid Metabolism
GgaAffx.24836.1.S1_at 2.5 0.001 0.27 chr1: 100587339–100699482 XM_416725 propionyl-Coenzyme A-carboxylase
GgaAffx.22084.1.S1_at 1.8 0 0.27 chr11: 59355–69450 No record lysophospholipase 3
Gga.150.1.S1_at 4.2 0.003 0.279 chr1: 167849591–167950628 NM_204252 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)
GgaAffx.8095.1.S1_at 1.6 0.006 0.324 chr1: 52216531–52245657 XM_416329 N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
Gga.879.1.S1_at -6.7 0.001 0.27 chr11: 16001674–16006281 NM_205526 N-acetyltransferase
Gga.19791.1.S1_s_at 1.9 0.003 0.279 chr2: 128797196–128808892 XM_418378 low density lipoprotein-related protein 12
GgaAffx.9942.1.S1_at 2.2 0.001 0.27 chr4: 81245396–81273837 XM_420814 acyl-CoA oxidase
GgaAffx.20938.1.S1_at 1.3 0.007 0.329 chr5: 15830450–15831289 NM_001031187 pyruvate dehydrogenase complex, component X similar to glycerol-3-phosphate dehydrogenase 2;
GgaAffx.23939.1.S1_s_at 7.5 0.005 0.301 chr7: 36699654–36750512 XM_422168 glycerol phosphate dehydrogenase 1, mitochondrial; FAD-linked glycerol-3-phosphate dehydrogenase
Gga.17037.1.S1_s_at 1.6 0.005 0.308 chrZ: 15403025–15434404 NM_001031422 phosphatidylinositol-4-phosphate 5-kinase, type I, beta
GgaAffx.5721.1.S1_at 2.1 0.001 0.27 chr3: 9206064–9214413 NM_001031039 lysocardiolipin acyltransferase
Energy Metabolism
Gga.11825.1.S1_at 3.2 0.003 0.274 chr1: 109208120–109232230 XM_416788 glycerol kinase
Gga.9828.1.S1_a_at -3.2 0 0.27 chr1: 79394222–79396236 XM_416612 thioredoxin-like 4B
GgaAffx.4389.1.S1_at -1.6 0.004 0.284 chr10: 17276047–17283495 XM_425083 5-oxoprolyl-peptidase
GgaAffx.2243.2.S1_at 2.3 0.002 0.27 chr26: 3685185–3702282 XM_418055 ATPase, Ca++ transporting, plasma membrane 4
Gga.19534.1.S1_at 8.3 0.002 0.27 chr9: 21559961–21563214 ">XM_422814"> beta 1,3-galactosyltransferase, polypeptide 3
Tumorigenesis
Gga.6519.1.S1_s_at -2.2 0.005 0.303 chr1: 21687403–21784133 XM_416014 suppression of tumorigenicity 7
Gga.15871.1.S1_at -1.6 0.006 0.323 chr19: 8852117–8853712 CR387378 Tumor necrosis factor, alpha-induced protein 1
Gga.12058.1.S1_at 2.1 0.003 0.279 chr2: 135144222–135145306 XM_418407 similar to cylindromatosis (turban tumor syndrome); cylindromatosis 1, turban tumor syndrome
GgaAffx.22987.1.S1_at -1.6 0.002 0.27 chr5: 26523325–26529591 XM_421205 thrombospondin 1
Gga.654.1.S2_at 1.8 0.001 0.27 chr6: 4237546–4314610 NM_205190 ret proto-oncogene
Signal Transduction
GgaAffx.3663.1.S1_at -5.3 0.003 0.278 chr14: 8517712–8520620 XM_414857 similar to CASK interacting protein 1
Gga.12193.1.S1_a_at 9.0 0.007 0.324 chr2: 47562155–47581032 XM_418851 G-substrate
Gga.9510.1.S1_at 1.9 0.007 0.329 chr22:537865–569787 NM_001030886 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform
Gga.1761.2.S1_at 13.8 0.002 0.27 chr3:107742849–107744353 XM_420066 similar to G-protein coupled receptor 116
GgaAffx.4775.1.S1_s_at 4.0 0.002 0.27 chr4:11707299–11760821 XM_420292 similar to receptor tyrosine kinase flk-1/VEGFR-2B
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Gga.807.1.S1_at 1.9 0.007 0.324 chr4:65686004–65686340 NM_001004368 kinase insert domain receptor (a type III receptor tyrosine kinase) (KDR)
Gga.12481.1.S1_s_at 1.9 0.007 0.327 chr7:27843665–27860405 NM_001012920 protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b
Gga.6653.1.S1_at -1.7 0.004 0.281 chr11:17426083–17429654 NM_001030576 hepatic nuclear factor 4beta similar to suppressor of cytokine signaling 7; SH2
GgaAffx.8729.1.S1_s_at -10.0 0 0.27 chrUn:137141542–
137146475
XM_423895 domain containing SOCS box protein SOCS7; Nck, Ash and phospholipase C binding protein similar to 
prostaglandin E receptor 3; Rat kidney
GgaAffx.7207.1.S1_at 5.7 0.002 0.27 chr8:29278163–29285596 XM_426672 prostaglandin EP3 receptor (alternative splicing results in two different receptors EP3a and EP3b);
Gga.10737.1.S1_s_at 1.7 0.005 0.305 chr7:2212065–2223469 XM_421856 similar to Nck-associated protein 1 (NAP 1) (p125Nap1) (Membrane-associated protein HEM- 2)
GgaAffx.8719.1.S1_at 7.2 0.002 0.27 chr4:64869759–64912904 XM_420693 similar to regulator protein p122-RhoGAP – rat
Gga.12408.3.S1_a_at 2.7 0.005 0.305 chr5:41375030–41383659 NM_204357 ataxin 3
Gga.323.1.S1_at 3.6 0.001 0.27 chrUn:147862083–
147882739
NM_204801 tetraspanin 18
Immunity
Gga.13806.1.S1_at -4.8 0.004 0.293 chr7:7186627–7189336 NM_204240 adenosine deaminase, RNA-specific, B1 (RED1 homolog rat)
Gga.18504.1.S1_at 6.9 0.003 0.278 chr5:5440836–5460278 CR390783 parvin, alpha
Gga.698.1.S1_at 1.6 0.004 0.293 chr6:14652488–14704778 NM_205441 vinculin
Gga.11155.1.S1_s_at 1.8 0.001 0.27 chr4:15341234–15354773 XM_420331 stromal antigen 2
Others
Gga.11258.1.S1_at 1.7 0.001 0.27 chr1:170378838–170513289 XM_417140 EF-hand domain family, member A1
Gga.15085.2.S1_s_at 6.6 0.001 0.27 chr1:172635432–172645292 XM_417167 CWF19-like 2, cell cycle control (S. pombe)
GgaAffx.5969.1.S1_at 6.2 0.002 0.27 chr1:24071401–24234367 XM_416024 similar to dedicator of cytokinesis 4
GgaAffx.12338.1.S1_s_at 3.9 0.001 0.27 chr15:7114454–7122253 NM_001030665 tuftelin interacting protein 11
GgaAffx.25724.1.S1_s_at 7.4 0.002 0.27 chr18:5638526–5691321 XM_415648 similar to Stxbp4 protein
GgaAffx.6849.1.S1_at 4.0 0.004 0.285 chr3:34026676–34050970 XM_419554 similar to endoplasmic reticulum oxidoreductin 1- Lbeta
GgaAffx.22370.3.S1_s_at 4.3 0 0.27 chr3:1260579–1276286 XM_420116 similar to chromosome 17 open reading frame 28; downregulated in multiple cancer 1
GgaAffx.6334.2.S1_at 3.9 0.004 0.293 chr4:33725503–33732138 XM_420444 SH3 domain protein D19
GgaAffx.22790.1.S1_s_at 6.1 0.003 0.279 chr6:26875122–27047419 XM_421771 similar to actin-binding LIM protein 1 medium isoform
GgaAffx.26704.1.S1_at -5.2 0.001 0.27 chr8:14622890–14638649 XM_422345 similar to abhydrolase domain containing 7
Gga.16560.1.S1_at 3.3 0.003 0.279 chrE26C13:1961–7813 XM_422853 myeloid cell leukemia sequence 1 (BCL2-related)
Gga.16020.1.S1_at 2.2 0 0.27 chrUn:92422001–92432256 NM_001031613 similar to Death-associated protein kinase 1
Table 5: Differentially expressed genes by microarray analysis (Continued)BMC Genomics 2007, 8:193 http://www.biomedcentral.com/1471-2164/8/193
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AFP is 0.1765(P < 0.01) at 7 wk of age based on data of
eighth generation population, and the heritability of AFW
and AFP were calculated based on the pedigree of eighth
generation using the software MTDFREML. The heritabil-
ity of AFW and AFP at G8 was considered high: AFW is
0.55, and AFP is 0.57.
Sample preparation
Birds were slaughtered at 7 weeks and abdominal fat was
isolated, immediately frozen in liquid nitrogen and stored
at -80°C. The ten birds used in the present study were cho-
sen by the percentage of abdominal fat (AFP): five had the
highest AFP and the other five had the lowest (Table 1).
Total RNA was extracted from 300 to 800 mg bulk abdom-
inal adipose tissue using an RNeasy Lipid Tissue Mini Kit
(QIAGEN, Valencia, CA) according to the manufacturer's
recommendations, and quantified by spectrophotometry.
mRNA was isolated using an Oligotex mRNA Mini Kit
(QIAGEN, Valencia, CA). cDNA was prepared by oligo-
dT-primed reverse transcription using Superscript II (Life
Technologies, Inc.). Labeled cRNA probes were prepared
using an IVT Labeling Kit (Affymetrix, Inc.) according to
the manufacturer's protocol.
Table 7: Comparison of microarray and real-time RT-PCR analyses
Gene Microarraya Real-time RT-PCR
Fold change(F/L)b Fold change(F/L)b Student T-testc (p-value)
PCC 2.5 2.45 0.0312*
ATXN3 2.7 4.47 0.0241*
PER 5.67 8.08 0.007**
ERO1 3.94 3.66 0.0308*
FLT1 4.21 4.46 0.0455*
CWF19 6.56 1.95 0.03*
PBP2 6.95 5.75 0.0521
PARVA 6.90 3 0.0221*
G3PD 7.46 2.32 0.0154*
Stxbp4 7.35 2.8 0.0031**
LRP12 1.82 8.83 0.0404*
ACO 2.19 2.76 0.2912
ST7 -2.1 -2.07 0.0042**
SOCS7 -10.0 -1.41 0.2117
TNFAIP1 -1.6 1.72 0.0086**
a: Microarray F/L fold changes are taken from Table 5.
b: Fold changes (F/L: mean of fat sample values on mean of lean sample values).
c:Student's t-test p-values, *p < 0.05, **p < 0.01.
Table 6: Primer pairs used to analyze gene expression by quantitative RT-PCR, and size of product
Gene Forward primera Reverse primera Size
PCC AGGGAAAGGTCGTGGCG CCACTGCCAAGGACACTAGG 137 bp
PBP2 GAGTAAAGTCCGAGAACGAATG AAATCCAGTAGTGGGACAAAGG 185 bp
TNFAIP1 TTCACTCTTAGAAATGCTGGTG CTAAGTTAGTGGCAAAGCTGG 169 bp
FLT1 CTCTTTGGCATGAAAGGTGTC CGTAGGTGTATCTTCGCTTGG 124 bp
G3PD CTCCCATCCCATACCGACAG GGCATATCGACTGCGTGTCC 167 bp
LRP12 GGAGTGTCAACGGCTTGTGG ATCGGCGTGATCCCTGAACA 184 bp
PER GGATCATGTGCGTCCTGTC GGAGCAGCAGATAAACCCAC 210 bp
ST7 GTTCTATGTTGCCTTGACAGG AAGTGGCTCACCGAGACCT 120 bp
ERO1 TTCAAGCCTCGATCTGTCTA TCAAGAAGATAATTGGCACAC 182 bp
ATXN3 AAAGGTGACCTGCCAGAC TTGCTTGGTCCACATCAC 142 bp
PARVA GTGTACTTAGTCCTGCTAATGGG TCTGGTCTGGGCTTTGGTT 161 bp
CWF19 ATCCCAGGGAAGTCTCGC CTTTAGGCTCCTGTGGTTCAG 127 bp
Stxbp4 CCAAGATTTGAGAAAGAGGGTT TCACTTAGAACAGCCGAGGAA 162 bp
ACO GCTGTGCTCTATCAAGGTGGC ACAAGGGCAACTGCGTCATC 110 bp
SOCS7 CATCCCAAGTTTGAAGACCG CATTGCTGAACCTGGAGACG 163 bp
GAPDH AGAACATCATCCCAGCGT AGCCTTCACTACCCTCTTG 184 bp
a,: Sequences of oligonucleotides are indicated from 5' to 3' endBMC Genomics 2007, 8:193 http://www.biomedcentral.com/1471-2164/8/193
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Microarrays, hybridization and scanning
The GeneChip Chicken Genome Array used in present
study was created by Affymetrix Inc. at the end of 2004,
with comprehensive coverage of over 38,000 probe sets
representing 32,773 transcripts corresponding to over
28,000 chicken genes. The Chicken Genome Array also
contains 689 probe sets for detecting 684 transcripts from
17 avian viruses. Sequence information for this array was
selected from the following public data sources: GenBank,
UniGene (Build 18; May, 2004) and Ensembl (version 1,
released on May, 2004).
Twenty micrograms of cRNA were fragmented at 94°C for
35 min in a 5 × fragmentation buffer containing 200 mM
Tris-acetate (pH 8.1), 500 mM KOAc, 150 mM MgOAc.
Prior to hybridization, the fragmented cRNA was heated
at 95°C for 5 min in 1 × MES hybridization buffer (100
mM MES, 1 M NaCl, 20 mM EDTA, 0.01% Tween20) and
0.1 mg/ml herring sperm DNA, then at 45°C for 5 min,
before loading on to the Affymetrix probe array cartridge
(Affymetrix, Inc.). After prehybridization in 300 µl 1 ×
Hybridization Buffer at 45°C for 10 min, the Chicken
Genome Arrays were incubated for 16 h at 45°C at con-
stant rotation (60 rpm) using the manufacturer's hybridi-
zation buffer. Following hybridization, the arrays were
washed with 6 × SSPE-T (0.9 M NaCl/60 mM NaH2PO4/6
mM EDTA/0.01% Tween20) at 25°C on a fluidics station
(Affymetrix) for 10 × 2 cycles, then washed with 0.1 M
MES/0.1 M NaCl/0.01% Tween20 at 50°C for 4 × 15
cycles. The arrays were stained with a streptavidin-phyco-
erythrin conjugate (Molecular Probes, Eugene, OR), fol-
lowed by 10 × 4 wash cycles. To enhance the signals, the
arrays were further stained with anti-streptavidin anti-
body for 10 min followed by a 10-minute staining with
the streptavidin-phycoerythrin conjugate. After 15 × 4
additional wash cycles, the arrays were scanned at 560 nm
using a confocal scanner (Affymetrix Gene array
Scanner3000).
Microarray data normalization
Raw data sets were normalized to total fluorescence,
which represents the total amount of cRNA hybridized to
a microarray, using the software Affymetrix Microarray
Suite 4.0. Data sets were excluded if the absolute call (Abs
Call) was A (absent) or M (Marginal) according to the
detection p-value in all arrays. Only expressed transcripts
(the Abs Call was P, present) were used in further analysis.
The raw data have been deposited in the National Center
for Biotechnology Information (NCBI) Gene Expression
Omnibus and have been assigned the following GEO
accession numbers: GSM197816, GSM197817,
GSM197818, GSM197819, GSM197820, GSM197821,
GSM197822, GSM197823, GSE197824 and GSE197825
Analysis of gene expression profile in 7-week broilers
The gene expression profile was investigated by three
methods. First, according to the data normalization and
Affymetrix Microarray Suite 4.0 software results, a gene
was considered "not detected" by the scanner if its abso-
lute call was A; we call these genes "not expressed" in this
paper. The distribution of the expressed transcript (the
Abs Call was P) was characterized by JMP4.0 according to
its expression level, and genes with high and low expres-
sion levels were defined on the basis of this result.
Hierarchical clustering analysis of the variation within 
each line
The fat and lean chicken lines have been selected for eight
generations, so it is expected that the differences among
individuals within each line are slight. Hierarchical clus-
tering analysis of the genes expressed in five birds from
each line was conducted to measure the consistency
within each line. The value of R (coefficient correlation)
was calculated and used to evaluate inter-line variation.
Any individual that deviated too much from the others
was excluded from the subsequent screening for differen-
tially expressed genes.
Identification of differentially expressed genes
Differentially expressed genes were identified from nor-
malized data using the Significance Analysis of Microar-
rays (SAM) algorithm [8] implemented in a TIGR
MultiExperiment Viewer. According to the SAM algo-
rithm, genes are identified as differentially expressed on
the basis of expression differences among the sample
groups and the consistency of these differences; a score is
assigned to each gene on the basis of a change in its
expression relative to the standard deviation of repeated
measurements for that gene. A gene is deemed 'significant'
if its score surpasses a certain threshold. SAM calculates a
false discovery rate (FDR), which is the median percentage
of genes that are likely to be identified as significantly
changed by chance. The threshold can be adjusted to iden-
tify different sets of putatively significant genes and the
FDR is changed accordingly. The number of significantly
changed genes in each experiment depends on a threshold
with an acceptable FDR, selected by the investigator
[8,30,31]. Clustering was achieved using uncentered Pear-
son correlations and average linkage clustering, and was
displayed in TreeView. In the present study, a ?-value of
0.8 was chosen, giving a reasonable cutoff of 3.13 and
4.73 in d-scores.
Real-time quantitative RT-PCR
Oligonucleotide primers were designed to amplify a frag-
ment containing sequences from two adjacent exons in
order to avoid contamination with genomic DNA. Glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) was
considered to be a stably expressed housekeeping geneBMC Genomics 2007, 8:193 http://www.biomedcentral.com/1471-2164/8/193
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and was used as an internal reference gene. The primer
pairs used to analyze gene expression and the size of prod-
uct are shown in Table 6.
cDNA was prepared using an RNA PCR Kit (AMV) Ver3.0
(Takara) starting with 500 ng of total RNA from the fol-
lowing samples: (1) fat line: 7-3-3, 7-3-8, 7-3-15, 7-3-16,
7-3-24; (2) lean line: 7-1-1, 7-1-2, 7-1-4, 7-1-11, 7-1-17;
(3) four RNA pools (two from each line), each containing
three samples that were not used for the array experi-
ments. First-strand cDNA synthesis was performed at
42°C for 30 min. The 10 µl reaction mixture also con-
tained 1 × AMV reaction buffer, 1 mM each dNTP, 0.125
pmol oligo-dT-adaptor primer, 5 mM MgCl2, 10 U RNase
inhibitor, and 2.5 U avian myeloblastosis virus (AMV)
reverse transcriptase XL. After incubation, the mixture was
heated at 99°C for 5 min to extinguish reverse tran-
scriptase activity. Relative quantification of the expression
of selected genes was performed using SYBR® Premix Ex
Taq™ (Takara). The reaction mixtures were incubated in
an ABI Prism 7300 Sequence Detection System (Applied
Biosystems) programmed to conduct one cycle at 95°C
for 10 s and 40 cycles at 95°C for 5 s and 60°C for 31 s.
The dissociation curves were analyzed using Dissociation
Curve 1.0 software (ABI) for each PCR reaction to detect
and eliminate possible primer-dimer artifacts. Results
(fold changes) were expressed as 2∆∆Ct with ∆∆Ct = (Ctij -
CtGAPDHj) - (Cti1 - CtGAPDH1), where Ctij and CtGAP-
DHj are the Ct for gene i and for GAPDH in a pool or a
sample (named j), and Cti1 and CtGAPDH1 are the Ct in
pool 1 or sample 1, expressed as the standard [9].
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